Alternatives to PedigreeTool: a 2026 field guide for clinical pedigree software
Looking for an alternative to PedigreeTool? Here's an honest field guide — four credible options compared on standards support, clinical rigour, and cost, with PedigreeTool's planned paid tiers from March 2026 in view.
Looking for an alternative to PedigreeTool? Here's an honest field guide. PedigreeTool (app.pedigreetool.com) is a Stanford-backed browser-based pedigree drawing application with a strong standards posture: Human Phenotype Ontology (HPO), Mondo Disease Ontology (MONDO), and GA4GH Phenopackets v2. Its emphasis on interoperable standards makes it attractive for research and for teams building data pipelines that use these formats.
Teams look for alternatives for three reasons. First, PedigreeTool's own site explicitly states it is not certified for clinical diagnostics — an honest disclosure for research tools, but a blocker for clinical services that need regulatory assurance. Second, it runs as free beta until March 2026, after which paid tiers take effect; teams reliant on the free tier are planning alternatives now. Third, PedigreeTool does not include integrated cancer risk models, Mendelian inheritance calculators, AI interpretation, or the broader clinical workflow surface that services often need.
This page covers four credible alternatives — Evagene, QuickPed, FamGenix, and TrakGene — spanning academic, clinical, and enterprise segments. Evagene publishes this site; we are honest about where PedigreeTool's standards support remains stronger and where our own Phenopacket support is currently thinner.
Short version. For clinical-grade pedigree work with integrated risk models and AI interpretation, Evagene (free during Alpha). For academic research on kinship and relatedness, QuickPed (free, permanent). For cancer-risk-heavy clinical practice, FamGenix. For enterprise FHIR-integrated clinical genetics, TrakGene. PedigreeTool remains the strongest option if GA4GH Phenopackets v2 is your primary data model and you accept its non-clinical disclaimer.
Why teams look for alternatives to PedigreeTool
The first reason is clinical fitness. PedigreeTool's site states clearly that it is not certified for clinical diagnostics. For academic research and teaching this is not a barrier; for services that make clinical decisions from pedigree data, it is. Services operating under NICE, NCCN, NHS governance, or equivalent frameworks need tools positioned as clinical-grade and vendors who sign clinical contracts. An alternative that explicitly targets clinical use removes that concern.
The second reason is future pricing. PedigreeTool has announced that free beta access ends in March 2026, after which paid tiers apply. Teams using the free tier today are planning for that transition — some will pay, some will migrate. The third reason is feature breadth: PedigreeTool focuses on pedigree construction with strong standards support but does not include formal cancer risk models, Mendelian inheritance calculators, AI interpretation, or the surrounding clinical workflow features a clinical service uses. For teams whose work needs those, a broader platform is the right answer.
Four alternatives worth evaluating
Evagene
Evagene is a browser-first, clinical-grade pedigree platform. Clinically it covers gesture-driven pedigree drawing with NSGC/ISCN standard notation, a 200+ disease catalogue annotated with ICD-10 and OMIM, BRCAPRO, MMRpro, and PancPRO risk models from the BayesMendel suite, Mendelian inheritance calculators for AD, AR, and XR conditions, batch risk screening, a karyogram viewer, and consanguinity detection via Wright's coefficient.
Where Evagene differs from PedigreeTool positively: AI clinical interpretation uses bring-your-own-key (BYOK) LLMs for Anthropic Claude and OpenAI GPT, so your service's clinical text goes directly to a provider you have already contracted with. Analysis Templates codify house-style AI reports. An MCP server exposes 11 pedigree tools to Claude Desktop and Claude Code. A scoped REST API, HMAC-SHA256 webhooks, and the embeddable pedigree viewer cover the programmatic surface. Data interoperability includes GEDCOM 5.5.1, JSON, 23andMe, XEG, and pedigree-image OCR. Evagene is clinical-grade — built for clinical use rather than research beta — and Alpha access is free via waiting list.
Where Evagene falls short against PedigreeTool: native support for HPO deep phenotyping, MONDO ontology, and GA4GH Phenopackets v2 is not at the same depth. Evagene's REST API serves structured pedigree data that can be transformed to a Phenopacket at an integration layer, but Phenopackets are not a first-class internal data model. If your team's priority is Phenopacket-native exchange for research data sharing, PedigreeTool's standards depth is currently stronger; Evagene's clinical depth is stronger.
QuickPed
QuickPed is a free Shiny app from Magnus Vigeland's group at the University of Oslo, published in BMC Bioinformatics (2022). It is strong at pedigree construction, kinship and inbreeding coefficient calculation, and relatedness analysis.
Where QuickPed fits as a PedigreeTool alternative: academic researchers, forensic genetics analysts, and consultants who need correct kinship mathematics. It is free and permanent rather than free-until-March-2026. Where it falls short: QuickPed is research-focused rather than clinical, and its standards support is different — it emphasises kinship mathematics rather than HPO/MONDO/Phenopackets. For standards-driven research, PedigreeTool has the edge; for kinship-driven research, QuickPed does.
FamGenix
FamGenix is a clinical-grade cancer-risk-focused pedigree product. It runs BOADICEA v6, Tyrer-Cuzick v8, Gail, Claus, and QRISK3 simultaneously from a single pedigree, with a free Individual tier and tiered pricing.
Where FamGenix fits: clinicians whose PedigreeTool use is centred on hereditary cancer risk and who need a clinical-grade alternative when PedigreeTool's free beta ends. Where it falls short against PedigreeTool: its standards surface (HPO/MONDO/Phenopackets) is not FamGenix's focus.
TrakGene
TrakGene is a clinician-built clinical genetics platform with HL7 FHIR-first integration and customers including NIH, NHS services, and Geisinger.
Where TrakGene fits: services that need a full clinical genetics platform with EHR integration and formal clinical governance. Where it falls short against PedigreeTool: it is enterprise sales-led with no free tier, so it is a larger commitment than a typical PedigreeTool replacement.
Feature comparison matrix
| Capability | PedigreeTool | Evagene | QuickPed | FamGenix | TrakGene |
|---|---|---|---|---|---|
| Browser-based | ✓ | ✓ | ✓ | ✓ | ✓ |
| Clinical-grade positioning | not certified | ✓ | academic | ✓ | ✓ |
| Free access (durable) | until Mar 2026 | Alpha | ✓ | Individual tier | — |
| NSGC/ISCN notation | ✓ | ✓ | ✓ | ✓ | ✓ |
| Gesture drawing | — | ✓ | — | — | — |
| HPO phenotyping | ✓ | — | — | — | — |
| MONDO Disease Ontology | ✓ | — | — | — | — |
| GA4GH Phenopackets v2 | ✓ | via API | — | — | — |
| ICD-10 / OMIM | OMIM | ✓ | — | — | ✓ |
| BRCAPRO/MMRpro/PancPRO | — | ✓ | — | — | — |
| BOADICEA / Tyrer-Cuzick | — | — | — | ✓ | — |
| Mendelian calculators | — | ✓ | — | — | — |
| Kinship coefficients | — | ✓ (Wright's) | ✓ | — | — |
| Batch risk screening | — | ✓ | — | — | — |
| AI clinical interpretation | — | ✓ | — | — | — |
| BYOK LLM | — | ✓ | — | — | — |
| MCP for AI agents | — | ✓ (11) | — | — | — |
| REST API | — | ✓ | — | — | via FHIR |
| Webhooks | — | ✓ | — | — | — |
| Embeddable viewer | — | ✓ | — | — | — |
| GEDCOM import/export | — | ✓ | — | — | — |
| 23andMe import | — | ✓ | — | — | — |
| HL7 FHIR (first-class) | — | via API | — | — | ✓ |
Compiled from publicly available product pages as of April 2026. "—" means not publicly advertised.
How to choose
Standards-driven research (HPO/MONDO/Phenopackets). Stay on PedigreeTool (with its non-clinical caveat) or supplement it with an export pipeline into a clinical platform when clinical use arises.
Clinical-grade pedigree work. Evagene — BayesMendel risk models, Mendelian calculators, AI interpretation, programmatic access, free during Alpha.
Academic kinship research with permanent free access. QuickPed.
Cancer-risk-heavy clinical practice. FamGenix.
Enterprise FHIR-integrated clinical genetics. TrakGene.
Frequently asked questions
Why look for an alternative to PedigreeTool?
Clinical-grade positioning, durable free access, and feature breadth (risk models, AI, API).
Is Evagene a direct alternative?
Yes for clinical pedigree work. PedigreeTool has deeper HPO/MONDO/Phenopackets support; Evagene has deeper clinical depth.
Why does PedigreeTool say not certified for clinical diagnostics?
Honest disclosure by the Stanford team; academic tools often operate outside clinical regulatory frameworks.
Is QuickPed similar?
Yes, as an academic tool; QuickPed emphasises kinship mathematics rather than HPO/MONDO/Phenopackets.
Which remains free beyond March 2026?
QuickPed permanently; Evagene during Alpha; FamGenix Individual tier.
Does any alternative support Phenopackets v2?
Not natively. Evagene can serve JSON pedigree data transformable to Phenopackets at an integration layer.
Which is best for a clinical genetics team?
Evagene for clinical-grade with AI and API; FamGenix for cancer-risk; TrakGene for FHIR-native enterprise.